Prescription Information Modernization Act of 2026
Sponsored By: Senator Banks, Jim [R-IN]
Introduced
Summary
Authorizes electronic delivery of required drug prescribing information while protecting paper access for health care professionals. The bill would amend the Federal Food, Drug, and Cosmetic Act so manufacturers may provide required prescribing information for drugs covered by section 503(b)(1) electronically.
Show full summary
- Prescribers and dispensers would be able to elect to keep receiving all prescribing information in paper or request paper copies as needed.
- Manufacturers would be required to comply with all applicable labeling laws and to promptly provide any requested paper labeling at no extra cost.
- The Secretary of Health and Human Services would have to issue final regulations within one year and hold a public workshop within two years on format, accessibility, and usability. The rule would apply to drugs introduced or delivered for introduction into interstate commerce on or after the earlier of two years after enactment or the regulations' effective date.
Personalized for You
How does this bill affect your finances?
Personalize government policy and PRIA will tell you what this bill means for your household, plus every other piece of legislation we track. PRIA reads each provision against your financial profile to show you exactly what matters to your wallet.
Bill Overview
Analyzed Economic Effects
1 provisions identified: 0 benefits, 0 costs, 1 mixed.
Electronic prescribing info with paper option
If enacted, drug makers would be allowed to provide required prescribing information only by electronic means so long as labeling still meets all legal requirements. Manufacturers would have to let prescribers and dispensers choose to keep receiving full paper labeling or request paper copies as needed. After a paper request, the manufacturer would have to promptly send the requested paper copy at no extra cost. The Secretary of Health and Human Services would have to issue final regulations within 1 year and explain how health care professionals can get paper copies directly from manufacturers or distributors. The change would apply to drugs introduced or delivered for introduction into interstate commerce on or after the earlier of two years after enactment or the effective date of those final regulations.
Sponsors & CoSponsors
Sponsor
Banks, Jim [R-IN]
IN • R
Cosponsors
Sen. Booker, Cory A. [D-NJ]
NJ • D
Sponsored 8/4/2026
Roll Call Votes
No roll call votes available for this bill.
View on Congress.gov